ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 63 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $258 | +3125.0% | 203,229 | +928.5% | 0.00% | – |
| Q1 2023 | $8 | -100.0% | 19,760 | -39.5% | 0.00% | – |
| Q3 2022 | $23,000 | -17.9% | 32,642 | +134.3% | 0.00% | – |
| Q1 2022 | $28,000 | -85.7% | 13,933 | -62.6% | 0.00% | -100.0% |
| Q2 2021 | $196,000 | -33.8% | 37,239 | -41.6% | 0.00% | -33.3% |
| Q1 2021 | $296,000 | – | 63,715 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AdvisorShares Investments LLC | 610,045 | $2,014,000 | 0.47% |
| ETF MANAGERS GROUP, LLC | 1,814,328 | $5,987,000 | 0.13% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 72,169 | $238,000 | 0.06% |
| Bernardo Wealth Planning LLC | 27,219 | $89,000 | 0.03% |
| Affinity Asset Advisors, LLC | 13,285 | $44,000 | 0.02% |
| ALGERT GLOBAL LLC | 20,778 | $69,000 | 0.02% |
| ZEKE CAPITAL ADVISORS, LLC | 49,700 | $164,000 | 0.01% |
| Founders Capital Management | 2,000 | $18,000 | 0.01% |
| King Wealth Management Group | 16,000 | $53,000 | 0.01% |
| Penserra Capital Management LLC | 129,252 | $425,000 | 0.01% |